Tikvah management calls on quanterix to explain the egregious terms of convertible notes purchased from akoya biosciences

Charlotte, n.c.--(business wire)--tikvah management llc (together with its affiliates, “tikvah” or “we”), which owns approximately 1.5% of the outstanding common shares of quanterix corp. (“quanterix” or the “company”) (nasdaq: qtrx), today issued a statement calling on the company to explain its most recent purchase agreement for up to $30 million in convertible notes from akoya biosciences, inc. (“akoya”) (nasdaq: akya). tikvah's statement follows: “this announcement concerns us for several r.
AKYA Ratings Summary
AKYA Quant Ranking